Overview
Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients.
Dr. Markowski is highly rated in 12 conditions, according to our data. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Hormone Replacement Therapy (HRT), and Prostatectomy.
His clinical research consists of co-authoring 75 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5255 Loughboro Road Northwest, Building B, Building B, Washington, DC 20016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
MedStar Georgetown University Hospital
Bruce Cheson is an Oncologist in Washington, Washington, D.c.. Dr. Cheson is highly rated in 18 conditions, according to our data. His top areas of expertise are Follicular Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant.
Office
Sharon Savage is a Hematologist and an Oncologist in Bethesda, Maryland. Dr. Savage is highly rated in 19 conditions, according to our data. Her top areas of expertise are Dyskeratosis Congenita, Aplastic Anemia, Aase Syndrome, Hormone Replacement Therapy (HRT), and Bone Marrow Transplant.
Office
Blanche Alter is a Hematologist and an Oncologist in Rockville, Maryland. Dr. Alter is highly rated in 13 conditions, according to our data. Her top areas of expertise are Aase Syndrome, Dyskeratosis Congenita, Aplastic Anemia, Bone Marrow Transplant, and Hormone Replacement Therapy (HRT).
Frequently Asked Questions about Dr. Mark C. Markowski
How do I make an appointment with Dr. Mark C. Markowski?
You can book an appointment with Dr. Mark C. Markowski by calling their office at 202-660-6500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark C. Markowski a top-rated expert for Hormone Replacement Therapy (HRT)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark C. Markowski is classified as an Elite expert for Hormone Replacement Therapy (HRT), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark C. Markowski specialize in?
While Dr. Mark C. Markowski is a Oncology, they have specific expertise in Hormone Replacement Therapy (HRT), Prostate Cancer, and Renal Cell Carcinoma (RCC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Mark C. Markowski participate in research or clinical trials?
Yes. Dr. Mark C. Markowski has published 75 articles and abstracts on conditions like Hormone Replacement Therapy (HRT). You can view a list of Dr. Mark C. Markowski's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark C. Markowski accept my insurance?
Dr. Mark C. Markowski accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 202-660-6500 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Hormone Replacement Therapy (HRT)Dr. Markowski isElite. Learn about Hormone Replacement Therapy (HRT).
- Prostate CancerDr. Markowski isElite. Learn about Prostate Cancer.
- Distinguished
- Chromophobe Renal Cell CarcinomaDr. Markowski isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Markowski isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Markowski isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Markowski isDistinguished. Learn about Familial Wilms Tumor 2.
- Renal Cell Carcinoma (RCC)Dr. Markowski isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Wilms TumorDr. Markowski isDistinguished. Learn about Wilms Tumor.
- Advanced
- Adult Soft Tissue SarcomaDr. Markowski isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- NUT CarcinomaDr. Markowski isAdvanced. Learn about NUT Carcinoma.
- ProstatectomyDr. Markowski isAdvanced. Learn about Prostatectomy.
- Experienced
- Alveolar Soft Part SarcomaDr. Markowski isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Bladder CancerDr. Markowski isExperienced. Learn about Bladder Cancer.
- Bone TumorDr. Markowski isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Markowski isExperienced. Learn about Brain Tumor.
- Metastatic Brain TumorDr. Markowski isExperienced. Learn about Metastatic Brain Tumor.
- Muscle Invasive Bladder CancerDr. Markowski isExperienced. Learn about Muscle Invasive Bladder Cancer.